• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦 EORTC QLU-C10D 效用量表值。

Danish value sets for the EORTC QLU-C10D utility instrument.

机构信息

University Hospital of Psychiatry II, Medical University of Innsbruck, Anichstraße 36, 6020, Innsbruck, Austria.

University Hospital of Psychiatry I, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

Qual Life Res. 2024 Mar;33(3):831-841. doi: 10.1007/s11136-023-03569-w. Epub 2024 Jan 6.

DOI:10.1007/s11136-023-03569-w
PMID:38183563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10894119/
Abstract

PURPOSE

In this study, we developed Danish utility weights for the European Organisation for Research and Treatment of Cancer (EORTC) QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30.

METHODS

Following a standardized methodology, 1001 adult participants from the Danish general population were quota-sampled and completed a cross-sectional web-based survey and discrete choice experiment (DCE). In the DCE, participants considered 16 choice sets constructed from the key 10 dimensions of the QLU-C10D and chose their preferred health state for each one. Utility weights were calculated using conditional logistic regression with correction for non-monotonicity.

RESULTS

The sample (n = 1001) was representative of the Danish general population with regard to age and gender. The domains with the largest utility decrements, i.e., the domains with the biggest impact on health utility, were physical functioning (- 0.224), pain (- 0.160), and role functioning (- 0.136). The smallest utility decrements were observed for the domains lack of appetite (- 0.024), sleep disorders (- 0.057), and fatigue (- 0.064). Non-monotonicity of severity levels was observed for the domains sleep disturbances, lack of appetite, and bowel problems. Deviations from monotonicity were not statistically significant.

CONCLUSION

The EORTC QLU-C10D is a relatively new multi-attribute utility instrument and is a promising cancer-specific health technology assessment candidate measure. The country-specific Danish utility weights from this study can be used for cost-utility analyses in Danish patients and for comparison with other country-specific utility data.

摘要

目的

本研究旨在开发丹麦效用权重,用于欧洲癌症研究与治疗组织(EORTC)QLU-C10D,这是一种基于 EORTC QLQ-C30 的癌症专用效用工具。

方法

按照标准化方法,从丹麦普通人群中配额抽样了 1001 名成年参与者,并完成了一项横断面网络调查和离散选择实验(DCE)。在 DCE 中,参与者考虑了 16 个由 QLU-C10D 的 10 个关键维度构建的选择集,并为每个选择集选择了他们偏好的健康状态。使用具有非单调性校正的条件逻辑回归计算效用权重。

结果

样本(n=1001)在年龄和性别方面代表了丹麦普通人群。物理功能(-0.224)、疼痛(-0.160)和角色功能(-0.136)等领域的效用下降最大,即对健康效用影响最大的领域。观察到最小的效用下降是在缺乏食欲(-0.024)、睡眠障碍(-0.057)和疲劳(-0.064)等领域。睡眠障碍、缺乏食欲和肠道问题等领域观察到严重程度水平的非单调性。单调背离不具有统计学意义。

结论

EORTC QLU-C10D 是一种相对较新的多属性效用工具,是一种有前途的癌症特异性卫生技术评估候选衡量标准。本研究中的丹麦特定国家效用权重可用于丹麦患者的成本效用分析,并与其他特定国家效用数据进行比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f323/10894119/2ca3f0e448e0/11136_2023_3569_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f323/10894119/166a73081e4b/11136_2023_3569_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f323/10894119/2ca3f0e448e0/11136_2023_3569_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f323/10894119/166a73081e4b/11136_2023_3569_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f323/10894119/2ca3f0e448e0/11136_2023_3569_Fig2_HTML.jpg

相似文献

1
Danish value sets for the EORTC QLU-C10D utility instrument.丹麦 EORTC QLU-C10D 效用量表值。
Qual Life Res. 2024 Mar;33(3):831-841. doi: 10.1007/s11136-023-03569-w. Epub 2024 Jan 6.
2
Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire.欧洲癌症研究与治疗组织核心生活质量问卷C10D的日本价值集:一种基于欧洲癌症研究与治疗组织QLQ-C30癌症特异性生活质量问卷的多属性效用工具。
Qual Life Res. 2024 Jul;33(7):1865-1879. doi: 10.1007/s11136-024-03655-7. Epub 2024 May 9.
3
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30.澳大利亚 EORTC QLU-C10D 效用量表,这是一种多属性效用工具,源自癌症特异性生存质量问卷 EORTC QLQ-C30。
Pharmacoeconomics. 2018 Feb;36(2):225-238. doi: 10.1007/s40273-017-0582-5.
4
German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30.德国 EORTC QLU-C10D 价值体系,这是一种基于 EORTC QLQ-C30 的癌症特异性效用工具。
Qual Life Res. 2019 Dec;28(12):3197-3211. doi: 10.1007/s11136-019-02283-w. Epub 2019 Sep 4.
5
Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D.荷兰效用量表在 EORTC 癌症特异性效用工具中的应用:荷兰 EORTC QLU-C10D。
Qual Life Res. 2021 Jul;30(7):2009-2019. doi: 10.1007/s11136-021-02767-8. Epub 2021 Jan 29.
6
United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument.美国 EORTC QLU-C10D 效用算法,一种基于癌症特异性生活质量工具的多属性效用工具。
Med Decis Making. 2021 May;41(4):485-501. doi: 10.1177/0272989X211003569. Epub 2021 Apr 5.
7
U.K. utility weights for the EORTC QLU-C10D.英国针对欧洲癌症研究与治疗组织生活质量核心问卷-10维度的效用权重。
Health Econ. 2019 Dec;28(12):1385-1401. doi: 10.1002/hec.3950. Epub 2019 Sep 3.
8
French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30.法国 QLU-C10D 价值观量表,一种源自 QLQ-C30 的癌症特异性效用测量工具。
Appl Health Econ Health Policy. 2021 Mar;19(2):191-202. doi: 10.1007/s40258-020-00598-1.
9
The EORTC QLU-C10D: the Hong Kong valuation study.EORTC QLU-C10D:香港评估研究。
Eur J Health Econ. 2024 Jul;25(5):889-901. doi: 10.1007/s10198-023-01632-4. Epub 2023 Sep 28.
10
Chinese utility weights for the EORTC cancer-specific utility instrument QLU-C10D.QLU-C10D 量表的 EORTC 癌症特异性效用量表中国效用权重。
Qual Life Res. 2024 Dec;33(12):3335-3349. doi: 10.1007/s11136-024-03776-z. Epub 2024 Sep 13.

引用本文的文献

1
Norwegian and Swedish value sets for the EORTC QLU-C10D utility instrument.欧洲癌症研究与治疗组织生活质量核心问卷-10维度效用工具的挪威和瑞典价值集。
Qual Life Res. 2025 Feb;34(2):429-443. doi: 10.1007/s11136-024-03824-8. Epub 2024 Nov 5.
2
A comparison of measurement properties between EORTC QLU-C10D and FACT-8D in patients with hematological malignances.血液系统恶性肿瘤患者中欧洲癌症研究与治疗组织生活质量核心问卷-10维度(EORTC QLU-C10D)与癌症治疗功能评价系统-8维度(FACT-8D)测量属性的比较
Health Econ Rev. 2024 Oct 1;14(1):79. doi: 10.1186/s13561-024-00560-0.
3
Cost-effectiveness of proton beam therapy vs. conventional radiotherapy for patients with brain tumors in Sweden: results from a non-randomized prospective multicenter study.

本文引用的文献

1
Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends.离散选择实验在健康状态估值中的应用:进展与新趋势的系统综述。
Appl Health Econ Health Policy. 2023 May;21(3):405-418. doi: 10.1007/s40258-023-00794-9. Epub 2023 Mar 30.
2
Estimation of an EORTC QLU-C10 Value Set for Spain Using a Discrete Choice Experiment.使用离散选择实验估计西班牙的 EORTC QLU-C10 值集。
Pharmacoeconomics. 2021 Sep;39(9):1085-1098. doi: 10.1007/s40273-021-01058-x. Epub 2021 Jul 3.
3
Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review.
瑞典脑肿瘤患者质子束治疗与传统放疗的成本效益:一项非随机前瞻性多中心研究的结果
Cost Eff Resour Alloc. 2024 Sep 13;22(1):66. doi: 10.1186/s12962-024-00577-6.
4
Chinese utility weights for the EORTC cancer-specific utility instrument QLU-C10D.QLU-C10D 量表的 EORTC 癌症特异性效用量表中国效用权重。
Qual Life Res. 2024 Dec;33(12):3335-3349. doi: 10.1007/s11136-024-03776-z. Epub 2024 Sep 13.
过去和现在在癌症随机临床试验中使用患者报告结局测量的情况:系统评价。
Value Health. 2021 Apr;24(4):585-591. doi: 10.1016/j.jval.2020.11.004. Epub 2021 Feb 10.
4
United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument.美国 EORTC QLU-C10D 效用算法,一种基于癌症特异性生活质量工具的多属性效用工具。
Med Decis Making. 2021 May;41(4):485-501. doi: 10.1177/0272989X211003569. Epub 2021 Apr 5.
5
The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data.丹麦 EQ-5D-5L 值集:使用 cTTO 和 DCE 数据的混合模型。
Appl Health Econ Health Policy. 2021 Jul;19(4):579-591. doi: 10.1007/s40258-021-00639-3. Epub 2021 Feb 2.
6
Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D.荷兰效用量表在 EORTC 癌症特异性效用工具中的应用:荷兰 EORTC QLU-C10D。
Qual Life Res. 2021 Jul;30(7):2009-2019. doi: 10.1007/s11136-021-02767-8. Epub 2021 Jan 29.
7
French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30.法国 QLU-C10D 价值观量表,一种源自 QLQ-C30 的癌症特异性效用测量工具。
Appl Health Econ Health Policy. 2021 Mar;19(2):191-202. doi: 10.1007/s40258-020-00598-1.
8
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.哪些多属性效用仪器推荐用于成本效用分析?国家卫生技术评估(HTA)指南的回顾。
Eur J Health Econ. 2020 Nov;21(8):1245-1257. doi: 10.1007/s10198-020-01195-8. Epub 2020 Jun 8.
9
EORTC QLU-C10D value sets for Austria, Italy, and Poland.EORTC QLU-C10D 价值集适用于奥地利、意大利和波兰。
Qual Life Res. 2020 Sep;29(9):2485-2495. doi: 10.1007/s11136-020-02536-z. Epub 2020 May 26.
10
German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30.德国 EORTC QLU-C10D 价值体系,这是一种基于 EORTC QLQ-C30 的癌症特异性效用工具。
Qual Life Res. 2019 Dec;28(12):3197-3211. doi: 10.1007/s11136-019-02283-w. Epub 2019 Sep 4.